WALTHAM, Mass.-- (BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of the CorEvitas Systemic Lupus Erythematosus (SLE) Registry.

Panniculitis refers to a group of conditions characterised by inflammation in the subcutaneous fat layer beneath the skin Here are some remedies that can help you manage this condition this winter ...

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease. In this Care Cues, experts discuss strategies to promote shared decision-making with their SLE patients.

Neutrophilic panniculitis associated with rheumatoid arthritis (RA) is a condition described in 1988, 5 and is less frequent than erythema nodosum associated with this rheumatological disease. 6 It ...

A complex and mysterious disease, the causes of systemic lupus erythematosus (SLE) remain unknown. In a new study, researchers discovered a mechanism that may contribute to lupus development and a ...

Tumid lupus is a rare form of cutaneous lupus erythematosus. It causes a person to develop smooth, nonscarring pimples on their skin. These pimples are often pink-to-violet in color.

Case report In April 2008, a 44-year-old woman was admitted to the Rheumatology and Rehabilitation University Hospital with the aim of establishing a diagnosis of suspected systemic lupus ...

Incurable autoimmune disease Systemic Lupus Erythematosus (SLE): New genetic findings open up perspectives for future therapeutic approaches Date: January 14, 2024 Source: Technische Universität ...

Systemic lupus erythematosus (SLE) and primary biliary cirrhosis (PBC) are both chronic autoimmune diseases. PBC primarily affects the liver and is characterized by inflammation or swelling of the ...

Lupus erythematosus panniculitis (LEP) is one of these subtypes. It’s possible and even common to have LEP alongside other subtypes of lupus, but this won’t be true for everyone.

EP: 13. Future Treatment Landscape for Patients With LN Alvin Wells, MD, PhD: Let me start by giving an overview of systemic lupus erythematosus [SLE] and lupus nephritis.

Evidence-based recommendations on belimumab (Benlysta) for treating active autoantibody-positive systemic lupus erythematosus. Last reviewed: 15 December 2021 This guidance updates and replaces NICE ...